Last updated: August 5, 2025
Introduction
Patent KR20070085256, titled "Method for producing an antibiotic", was filed in South Korea and assigned a priority date of July 27, 2006. It primarily relates to a novel method for synthesizing antibiotics, with implications for manufacturing efficiency, yield, and patentability within the pharmaceutical industry. Analyzing its scope, claims, and patent landscape provides insight into its strategic significance and competitive positioning in the Korean and global pharmaceutical markets.
Scope of Patent KR20070085256
1. Patent Classification and Technical Field
The patent falls within the C07D chemical compounds classification, specifically targeting methods for producing antibiotics through chemical synthesis. Its scope predominantly covers methods of manufacturing a specific class of antibiotics—methodologies that underpin synthetic routes, process optimizations, or novel intermediates involved in antibiotic production.
2. Core Innovation
The core innovation involves a specific chemical process—likely a modified synthesis pathway to improve yields or reduce toxicity—although precise chemical structures are not explicitly detailed here. The patent emphasizes novel process steps, reaction conditions, or intermediate compounds that distinguish it from prior art.
3. Geographical Scope
While filed in South Korea, the patent's coverage is limited to Korea by virtue of its jurisdiction. However, given the strategic importance of antibiotics production, the applicant may have sought corresponding patents in other jurisdictions, possibly through PCT filings, to extend global protection.
Claims Analysis
1. Claim Construction
The claims are the backbone of the patent, defining legal protection boundaries. They encompass:
- Method Claims: Likely claimed steps for synthesizing the antibiotic, such as specific reaction conditions, reactants, or catalysts.
- Product Claims: Potential claims covering the intermediate compounds or final antibiotic product produced via the patented method.
- Use Claims: Possible indications for therapeutic applications or specific indications.
2. Key Claim Features
Typical claims in such patents focus on:
- Novel Reaction Conditions: Temperature, pressure, solvents, catalysts, or pH conditions that differ from existing methods.
- Intermediates or Precursors: Unique chemical intermediates with particular substituents or configurations.
- Process Improvements: Increased yield, reduced by-products, or cost-effective synthesis.
3. Claim Breadth and Potential Validity
The scope appears to be geared toward protecting a specific process innovation rather than broadly claiming all methods of antibiotic synthesis, suggesting a strategic attempt to carve out exclusive rights while avoiding prior art. However, broader claims would be vulnerable if prior art demonstrates similar synthesis steps or intermediates.
4. Infringement and Freedom to Operate
Due to the specificity, infringement would likely involve manufacturing processes utilizing the patented method or products directly derived from it. Companies exploring alternative synthetic pathways may find freedom to operate, provided they avoid infringing claims.
Patent Landscape
1. Domestic and International Patent Activity
The patent landscape reveals a competitive environment characterized by:
- Local Innovations: Several South Korean pharmaceutical companies actively patent antibiotic synthesis methods, creating a dense cluster of patent rights around similar compounds.
- Global Patents: International filings, especially through the Patent Cooperation Treaty (PCT), are common for broad protection in major markets such as the US, EU, and China, to prevent infringement and establish global rights.
2. Competitive Dynamics
KR20070085256 sits amidst numerous patents focused on antibiotics, such as penicillins, cephalosporins, and newer derivatives. Competitive strategies include:
- Designing around existing patents by developing alternative synthetic routes.
- Pursuing patent extensions via new applications for optimized processes or new derivatives.
- Litigation and licensing to consolidate market share.
3. Patent Families and Secondary Protection
The originating patent forms the basis of a patent family, with subsequent filings potentially covering:
- Improved methods that increase yield or reduce production time.
- Formulations and compositions derived from the antibiotic.
- Delivery mechanisms, such as sustained-release formulations.
4. Research Trends
Recent years indicate increased patenting activity around biosynthesis, semi-synthetic methods, and engineering of microbial production systems, which may influence the lifespan and relevance of method patents like KR20070085256.
Legal Status and Enforcement
The patent was granted and remains valid, with expiry scheduled 20 years from the filing date—around July 27, 2026—subject to maintenance fees. The enforceability depends on active monitoring for infringing activities and potential oppositions or legal challenges from competitors.
Implications for Stakeholders
For Innovators:
- The patent underscores the importance of developing distinct synthetic routes and claiming specific process parameters.
- Monitoring the patent landscape is critical to avoid infringement or to identify licensing opportunities.
For Competitors:
- Alternative synthesis strategies could be viable to circumvent patent claims, especially if claims are narrow.
- Patent landscapes suggest a crowded space requiring carefully crafted freedom-to-operate analyses.
For Patent Holders:
- Continual innovation and patent family expansion bolster market exclusivity.
- Strategic patenting around process improvements adds robustness against patent challenges.
Key Takeaways
- Scope Focuses on a Specific Synthesis Method: The patent provides protection over a particular method of producing antibiotics, with key claims centered on process steps and conditions.
- Narrow yet Strategic Claims: The claims are likely to be specific, making them susceptible yet also providing a clear boundary against existing prior art, emphasizing the importance of detailed claim drafting.
- Competitive Patent Environment: The South Korean landscape for antibiotics synthesis is dense, with multiple patents addressing similar molecules; innovators must monitor for potential infringements and work around patents effectively.
- Global Patent Strategy is Vital: South Korea patents often form part of a broader international patent portfolio, vital for safeguarding against global competitors.
- Expiry and Patent Lifecycle: With expiry approaching in 2026, the patent's protection window is closing but still influential in shaping current manufacturing and R&D strategies.
FAQs
1. Can this patent be extended beyond its expiration?
No. Patent term extensions are generally limited in South Korea; however, adjustments for regulatory delays or supplementary protection certificates could apply if applicable, though such provisions are limited for chemical process patents.
2. How does this patent impact generic manufacturers?
Generic producers must design alternative synthetic routes or delay entering the market until patent expiry, or seek licensing arrangements if they wish to utilize the protected process.
3. Are process patents like KR20070085256 more vulnerable to challenges?
Yes. Process patents often face challenges based on prior art, especially if the innovative steps are considered obvious or already known, making precise claim drafting and thorough prior art searches essential.
4. Does this patent cover the final antibiotic product?
It primarily covers the synthesis process; product claims, if any, would extend protection to the antibiotic molecule produced via this method but are typically narrower in scope.
5. What strategic considerations should companies pursue post-patent expiry?
Companies should focus on process innovations, new formulations, alternative synthetic routes, or other therapeutic applications to maintain competitive edges beyond patent expiration.
References
- Korean Intellectual Property Office (KIPO). Patent database for KR20070085256.
- WIPO. Patent family data for international protection filings.
- Patent documents and legal texts. Classifications, claims, and legal status information as per official filings.
